Incidence of Inflammatory Bowel Disease in Urban China: A Nationwide Population-based Study
Clinical Gastroenterology and Hepatology · 2023-12 · 21 (13) · 3379-3386.e29
DOI: 10.1016/j.cgh.2023.08.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2023-12. Verfasst von Lu Xu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Research Center of Clinical Epidemiology, Peking University Third Hospital, Haidian District, Beijing, China; Key Laboratory of Epidemiology of Major…. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Crohn Disease, Colitis, Ulcerative. Die Arbeit wurde bisher 150-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation.
Abstract (Originalsprache)
BACKGROUND & AIMS: Limited studies have evaluated the burden of inflammatory bowel disease (IBD) in China. We aimed to estimate the incidence of IBD including ulcerative colitis (UC) and Crohn's disease (CD) in urban China. METHODS: The national urban incidence in 2016 was calculated based on urban basic medical insurance from 2012 to 2016 in China by using a 4-year washout period. The incidence in Yinzhou District estimated from the Yinzhou electronic health care record database was used to test the accuracy of the results from insurance data. RESULTS: A total of 95,555 patients with IBD were identified. The incidence in 2016 was 10.04 (95% confidence interval, 6.95-13.71) per 100,000 person-years. The incidence rates of both UC and CD were higher among males than among females. There was a sharp increase in UC incidence before the age of 30 years and stabilization in later years (50-79 years old), whereas CD incidence peaked at 30 to 34 years old and experienced decline subsequently. The incidence of UC was much greater than that of CD, with a UC-to-CD incidence ratio of 12.61. The results from the Yinzhou database confirmed these results. CONCLUSIONS: This study is the first to draw a portrait of the distribution of IBD in urban China. The difference in IBD incidence between urban China and other countries suggests an association between the IBD burden and industrialization process. The accelerating urbanization and industrialization process in China, a country with a population of 1.4 billion people, will likely increase the burden of IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Center of Clinical Epidemiology, Peking University Third Hospital, Haidian District, Beijing, China; Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Haidian District…
- Healthcare Security Administration of Guangdong Province, Yuexiu District, Guangzhou, Guangdong, China.
- Department of Data Center, Yinzhou District Center for Disease Control and Prevention, Ningbo, Zhejiang, China.
- Department of Gastroenterology, Peking University Third Hospital, Haidian District, Beijing, China.
- Peking University Health Information Technology Co., Ltd., Haidian District, Beijing, China.
- Shanghai Songsheng Business Consulting Co., Ltd., Dongcheng District, Beijing, China.
Förderung
- China Postdoctoral Science Foundation
Zitieren
APA
Xu, L., He, B., Sun, Y., Li, J., Shen, P., Hu, L., Liu, G., Wang, J., Duan, L., Zhan, S., & Wang, S. (2023). Incidence of Inflammatory Bowel Disease in Urban China: A Nationwide Population-based Study. Clinical Gastroenterology and Hepatology, 21(13), 3379-3386.e29. https://doi.org/10.1016/j.cgh.2023.08.013
Vancouver
Xu L, He B, Sun Y, Li J, Shen P, Hu L, et al. Incidence of Inflammatory Bowel Disease in Urban China: A Nationwide Population-based Study. Clinical Gastroenterology and Hepatology. 2023;21(13):3379-3386.e29. doi:10.1016/j.cgh.2023.08.013
BibTeX
@article{Xu2023,
author = {Xu, Lu and He, Bingjie and Sun, Yexiang and Li, Jun and Shen, Peng and Hu, Liming and Liu, Guozhen and Wang, Jinxi and Duan, Liping and Zhan, Siyan and Wang, Shengfeng},
title = {Incidence of Inflammatory Bowel Disease in Urban China: A Nationwide Population-based Study},
journal = {Clinical Gastroenterology and Hepatology},
year = {2023},
volume = {21},
number = {13},
pages = {3379--3386.e29},
doi = {10.1016/j.cgh.2023.08.013}
}
EUVIMED